Lancashire Teaching Hospitals NHS Foundation Trust
Preston, United Kingdom
NCT Number: NCT06256107
Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication. The purpose of this study is to establish if Virtual Reality is useful for people with MND and if it helps improve their well being.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Preston, United Kingdom
Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication.
As people become increasingly immobile, they become restricted in their ability to perform activities of daily living, access the outdoors, participate in preferred occupational roles or engage in leisure activities. Consequently, there is a deterioration in their ability to experience well being and have quality of life. There is also a significant carer burden as the carer spends long hours in the day looking after the person. The average disease trajectory lasts between 3-5 years, followed by death. More recently, the use of Virtual Reality (VR) technology is being recognised in the field of health. This technology uses the interactions between an individual and a computer generated environment to stimulate different sensory modalities such as visual and auditory. The technology can be accessed commonly using head mounted goggles or head sets. The entertaining or stimulating effect of VR is useful in redirecting the person's attention away from the distressing experiences, such as pain and anxiety. The purpose of this study is to establish if VR is useful for people with MND and if it helps improve their well being.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Virtual Reality Headset
Time frame: 4 weeks
Quality of Life (Scale 0-10 higher being better)
Time frame: 4 weeks
Cognition measure scale varied per question (Scale 0-8, 0-10, 0-12 higher being better)
Time frame: 4 weeks
scale for depression (Scale 0-27 - higher being worse)
Time frame: 4 weeks
scale for anxiety (Scale 0-3 where higher is worse outcome)
Time frame: 4 weeks
test of function (Yes or No - ability to perform function)
Lancashire Teaching Hospitals NHS Foundation Trust
Other
Exploring the Use of Virtual Reality Applications in Patients With a Diagnosis of Motor Neurone Disease
Acronym: VR in MND
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04695210
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Bedford, United Kingdom
View Trial DetailsNCT02464748
Motor Neuron Disease, Nervous System Diseases
Sheffield, United Kingdom
View Trial DetailsNCT02360891
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Angers, France
View Trial DetailsNCT03487263
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Herston, Queensland, Australia
View Trial Details